Tag: China

first-n-vivo-beta-thalassemia-trial-by-chinese-biotech-what-to-expect

First In Vivo Beta-Thalassemia Trial by Chinese Biotech: What to Expect

First In Vivo Beta-Thalassemia Trial by Chinese Biotech: A Groundbreaking Leap in Genetic MedicineIn a groundbreaking move that could revolutionize genetic medicine, Chinese biotech company YolTech Therapeutics has announced the initiation of the first...
news-19112024-182028

Merck Drug Trial and Wegovy in China: Pharmalittle News Update

Good day to you! The Pharmalot team is here, ready to dive into the latest news in the pharmaceutical world. Today, we have some interesting updates to share with you, so grab a cup...
news-14112024-161449

Merck Expands Portfolio with Licensing of Chinese Cancer Drug

Merck, a leading pharmaceutical company, has recently taken a strategic step to enhance its cancer drug portfolio by acquiring the licensing rights for a new cancer drug from LaNova Medicines, a Chinese firm based...

BREAKING NEWS

Top News